The Xpert Omni Performance Evaluation for Linkage to Tuberculosis Care (The XPEL TB Trial) is a multi-centre cluster-randomized trial that aims to compare patient outcomes at health centers randomized to intervention versus standard of care TB diagnostic evaluation strategies, to identify processes and contextual factors that influence the effectiveness and fidelity of the intervention TB diagnostic evaluation strategy and to compare the costs and epidemiological impact of intervention versus standard of care TB diagnostic evaluation strategies.
The overall goal of the study is to assess the effectiveness, implementation and costs of a streamlined TB diagnostic evaluation strategy based around rapid, onsite molecular testing.
XPEL-TB Team Members
Principal Investigators: Adithya Cattamanchi, Achilles Katamba
Co-Investigators: Luke Davis, David Dowdy, Priya Shete,
David Moore, Katherine Fielding
Collaborators: Sara Ackerman, Margaret Handley
Coordinator: Talemwa Nalugwa
Data Analyst: Katherine Farr, Tania Reza
Laboratory Technologist: Mariam Nantale
Research Assistants: Denis Oyuku, Annet Nakaweesa, Johnson Musinguzi